Andrea Finocchi

ORCID: 0000-0003-0958-8536
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Immunodeficiency and Autoimmune Disorders
  • Immune Cell Function and Interaction
  • Blood disorders and treatments
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • T-cell and B-cell Immunology
  • Chronic Lymphocytic Leukemia Research
  • Virus-based gene therapy research
  • DNA Repair Mechanisms
  • Parvovirus B19 Infection Studies
  • Blood groups and transfusion
  • CAR-T cell therapy research
  • Hematopoietic Stem Cell Transplantation
  • Diabetes and associated disorders
  • Platelet Disorders and Treatments
  • Inflammatory Bowel Disease
  • Neutropenia and Cancer Infections
  • Cystic Fibrosis Research Advances
  • SARS-CoV-2 and COVID-19 Research
  • Atherosclerosis and Cardiovascular Diseases
  • Nitric Oxide and Endothelin Effects
  • Neonatal Respiratory Health Research
  • Immune Response and Inflammation
  • Gastrointestinal disorders and treatments
  • Genetic Neurodegenerative Diseases
  • Pneumocystis jirovecii pneumonia detection and treatment

University of Rome Tor Vergata
2016-2025

Bambino Gesù Children's Hospital
2016-2025

Istituti di Ricovero e Cura a Carattere Scientifico
2010-2024

Federico II University Hospital
2022-2024

University of Brescia
2009-2022

University of Milan
2009-2022

Sapienza University of Rome
2006-2022

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
2015-2022

Weatherford College
2022

Azienda Ospedaliera Universitaria Pisana
2022

Wiskott-Aldrich syndrome (WAS) is an inherited immunodeficiency caused by mutations in the gene encoding WASP, a protein regulating cytoskeleton. Hematopoietic stem/progenitor cell (HSPC) transplants can be curative, but, when matched donors are unavailable, infusion of autologous HSPCs modified ex vivo therapy alternative approach. We used lentiviral vector functional WASP to genetically correct from three WAS patients and reinfused cells after reduced-intensity conditioning regimen. All...

10.1126/science.1233151 article EN Science 2013-07-12

Hemophagocytic lymphohistiocytosis (HLH) is characterized by immune dysregulation due to inadequate restraint of overactivated cells and associated with a variable clinical spectrum having overlap more common pathophysiologies. HLH difficult diagnose can be part inflammatory syndromes. Here, we identify novel hematological/autoinflammatory condition (NOCARH syndrome) in four unrelated patients superimposable features, including neonatal-onset cytopenia dyshematopoiesis, autoinflammation,...

10.1084/jem.20190147 article EN cc-by-nc-sa The Journal of Experimental Medicine 2019-10-10
Mehul Sharma Daniel Leung Mana Momenilandi Lauren C.W. Jones Lucia Pacillo and 89 more Alyssa James Jill R. Murrell Selket Delafontaine Jesmeen Maimaris Maryam Vaseghi‐Shanjani Kate L. Del Bel Henry Y. Lu Gilbert T. Chua Silvia Di Cesare Oriol Fornés Zhongyi Liu Gigliola Di Matteo Maggie P. Fu Donato Amodio Issan Yee San Tam Gavin S.W. Chan Ashish Sharma Joshua Dalmann Robin van der Lee Géraldine Blanchard-Rohner Susan Lin Quentin Philippot Phillip A. Richmond Jessica J. Lee Allison Matthews Michael Seear Alexandra K. Turvey Rachael L. Philips Terri F. Brown‐Whitehorn Christopher Gray Kosuke Izumi James R. Treat Kathleen H. Wood Justin Lack Asya Khleborodova Julie E. Niemela Xingtian Yang Rui Liang Lin Kui C. S. M. Wong Grace Wing-kit Poon Alexander Hoischen Caspar I. van der Made Jing Yang Koon Wing Chan Jaime S. Rosa Duque Pamela Lee M. Ho Brian Hon‐Yin Chung Huong Thi Minh Le Wanling Yang Pejman Rohani Ali Fouladvand Hassan Rokni‐Zadeh Majid Changi‐Ashtiani Mohammad Miryounesi Anne Puel Mohammad Shahrooei Andrea Finocchi Paolo Rossi Beatrice Rivalta Cristina Cifaldi Antonio Novelli Chiara Passarelli Stefania Arasi Dominique Bullens Kate Sauer Tania Claeys Catherine M. Biggs Emma Morris Sergio D. Rosenzweig John J. O’Shea Wyeth W. Wasserman H. Melanie Bedford Clara D.M. van Karnebeek Paolo Palma Siobhan O. Burns Isabelle Meyts Jean‐Laurent Casanova Jonathan J. Lyons Nima Parvaneh Anh Thi Van Nguyen Caterina Cancrini Jennifer Heimall Hanan Ahmed Margaret L. McKinnon YL Lau Vivien Béziat Stuart E. Turvey

STAT6 (signal transducer and activator of transcription 6) is a factor that plays central role in the pathophysiology allergic inflammation. We have identified 16 patients from 10 families spanning three continents with profound phenotype early-life onset immune dysregulation, widespread treatment-resistant atopic dermatitis, hypereosinophilia esosinophilic gastrointestinal disease, asthma, elevated serum IgE, IgE-mediated food allergies, anaphylaxis. The cases were either sporadic (seven...

10.1084/jem.20221755 article EN cc-by The Journal of Experimental Medicine 2023-03-08

Abstract Background Ataxia Teleangiectasia [AT] is a rare neurodegenerative disease characterized by early onset ataxia, oculocutaneous teleangiectasias, immunodeficiency, recurrent infections, radiosensitivity and proneness to cancer. No therapies are available for this devastating disease. Recent observational studies in few patients showed beneficial effects of short term treatment with betamethasone. To avoid the characteristic side long-term administration steroids we developed method...

10.1186/1750-1172-9-5 article EN cc-by Orphanet Journal of Rare Diseases 2014-01-09

Background— NADPH oxidase is believed to modulate arterial tone, but its role in humans still unclear. The objective of this study was evaluate whether involved flow-mediated dilation (FMD). Methods and Results— Twenty-five patients with hereditary deficiency gp91 phox , the catalytic core oxidase, (X-CGD), 25 healthy subjects, obese matched for sex age were recruited. FMD, platelet serum levels nitrite nitrate as markers nitric oxide generation, oxidized low-density lipoprotein, urinary...

10.1161/circulationaha.109.877191 article EN Circulation 2009-10-06

Platelet isoprostane 8-ISO-prostaglandin F2α (8-iso-PGF2α), a proaggregating molecule, is believed to derive from nonenzymatic oxidation of arachidonic acid. We hypothesized that NADPH implicated in formation and platelet activation.We studied 8-iso-PGF2α platelets 8 male patients with hereditary deficiency gp91(phox), the catalytic subunit oxidase, controls. On stimulation, controls produced 8-iso-PGF2α, which was inhibited -8% by aspirin -58% specific inhibitor gp91(phox). Platelets...

10.1161/atvbaha.110.217885 article EN Arteriosclerosis Thrombosis and Vascular Biology 2010-11-12

Mass SARS-Cov-2 vaccination campaign represents the only strategy to defeat global pandemic we are facing. Immunocompromised patients represent a vulnerable population at high risk of developing severe COVID-19 and thus should be prioritized in programs study vaccine efficacy. Nevertheless, most data on efficacy safety available vaccines derive from trials conducted healthy individuals; hence, studies immunogenicity SARS-CoV2 such populations deeply needed. Here, perform an observational...

10.3389/fimmu.2021.727850 article EN cc-by Frontiers in Immunology 2021-10-04

Memory B cells (MBCs) epitomize the adaptation of immune system to environment. We identify two MBC subsets in peripheral blood, CD27dull and CD27bright MBCs, whose frequency changes with age. Heavy chain variable region (VH) usage, somatic mutation replacement-to-silent ratio, CDR3 property changes, reflecting consecutive selection highly antigen-specific, low cross-reactive antibody variants, all demonstrate that MBCs represent sequential developmental stages, stringent antigen-driven...

10.1016/j.celrep.2020.02.022 article EN cc-by-nc-nd Cell Reports 2020-03-01

CD40 ligand (CD40L) expression on platelets is mediated by agonists, but the underlying mechanism still unclear.CD40L was measured in from healthy subjects both with and without addition of antioxidants or a phospholipase A2 (PLA2) inhibitor 2 patients an inherited deficiency gp91phox. Immunoprecipitation analysis also performed to determine whether normal showed gp91phox expression. Unlike catalase mannitol, superoxide dismutase inhibited agonist-induced platelet CD40L subjects. that...

10.1161/01.cir.0000134963.77201.55 article EN Circulation 2004-07-13

Abstract No controlled studies exist regarding the pharmaceutical reduction of ataxia symptoms in telangiectasia (A‐T). In a multicenter, double‐blind, randomized, placebo‐controlled crossover trial, oral betamethasone (BETA) and placebo were compared terms their as assessed with International Cooperative Ataxia Rating Scale (ICARS). this study 13 A‐T children, reduced ICARS total score by median points intent‐to‐treat population 16 per‐protocol (ie, percent decreases 28% 31%, respectively)....

10.1002/mds.25126 article EN Movement Disorders 2012-08-23

Gene therapy with ex vivo-transduced hematopoietic stem/progenitor cells may represent a valid therapeutic option for monogenic immunohematological disorders such as Wiskott-Aldrich syndrome (WAS), primary immunodeficiency associated thrombocytopenia. We evaluated the preclinical safety and efficacy of human CD34+ transduced lentiviral vectors (LV) encoding WAS protein (WASp). first set up validated transduction protocol derived from bone marrow (BM) or mobilized peripheral blood (MPB) using...

10.1038/mt.2012.23 article EN cc-by-nc-nd Molecular Therapy 2012-02-28

Ataxia-telangiectasia (AT) is a rare, devastating neurodegenerative disease presenting with early-onset ataxia, oculocutaneous telangiectasia, immunodeficiency, radiosensitivity, and proneness to cancer. In previous phase 2 study, we showed that 6 monthly infusions of autologous erythrocytes loaded dexamethasone (EryDex; EryDel, Urbino, Italy) were effective in improving neurologic impairment young patients AT. The present article reports the results extension this study for an additional...

10.1212/nxi.0000000000000098 article EN cc-by-nc-nd Neurology Neuroimmunology & Neuroinflammation 2015-04-10

As the global COVID-19 pandemic progresses, it is paramount to gain knowledge on adaptive immunity SARS-CoV-2 in children define immune correlates of protection upon immunization or infection. We analyzed anti-SARS-CoV-2 antibodies and their neutralizing activity (PRNT) 66 COVID-19-infected at 7 (±2) days after symptom onset. Individuals with specific humoral responses presented faster virus clearance lower viral load associated a reduced vitro infectivity. demonstrated that frequencies...

10.1016/j.celrep.2021.108852 article EN cc-by-nc-nd Cell Reports 2021-03-01
Coming Soon ...